DK3452050T3 - Composition comprising hmos for the treatment of noninfectious diarrhoea - Google Patents

Composition comprising hmos for the treatment of noninfectious diarrhoea Download PDF

Info

Publication number
DK3452050T3
DK3452050T3 DK17792540.1T DK17792540T DK3452050T3 DK 3452050 T3 DK3452050 T3 DK 3452050T3 DK 17792540 T DK17792540 T DK 17792540T DK 3452050 T3 DK3452050 T3 DK 3452050T3
Authority
DK
Denmark
Prior art keywords
hmos
noninfectious
diarrhoea
treatment
composition
Prior art date
Application number
DK17792540.1T
Other languages
English (en)
Inventor
Emma Elison
Bruce Mcconnell
Louise Kristine Vigsnaes
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60202765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3452050(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US15/147,112 external-priority patent/US20160243138A1/en
Application filed by Glycom As filed Critical Glycom As
Application granted granted Critical
Publication of DK3452050T3 publication Critical patent/DK3452050T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK17792540.1T 2016-05-05 2017-05-05 Composition comprising hmos for the treatment of noninfectious diarrhoea DK3452050T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/147,112 US20160243138A1 (en) 2014-10-29 2016-05-05 Composition comprising HMSs/HMOs and use thereof
PCT/DK2017/050145 WO2017190754A1 (en) 2016-05-05 2017-05-05 Composition comprising hmos for the treatment of non-infectious diarrhoea

Publications (1)

Publication Number Publication Date
DK3452050T3 true DK3452050T3 (da) 2023-02-20

Family

ID=60202765

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17792540.1T DK3452050T3 (da) 2016-05-05 2017-05-05 Composition comprising hmos for the treatment of noninfectious diarrhoea

Country Status (5)

Country Link
EP (1) EP3452050B1 (da)
DK (1) DK3452050T3 (da)
ES (1) ES2938355T3 (da)
PL (1) PL3452050T3 (da)
WO (1) WO2017190754A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
ES2938355T3 (es) 2016-05-05 2023-04-10 Glycom As Composición que comprende HMOS para el tratamiento de la diarrea no infecciosa
KR20200096263A (ko) 2017-11-30 2020-08-11 글리콤 에이/에스 밀 민감증을 치료하기 위한 hmo 혼합물
US20210239696A1 (en) * 2018-05-09 2021-08-05 Carbiotix Ab Method for measuring and improving gut health
BR112021011071A2 (pt) * 2018-12-19 2021-08-31 Glycom A/S Composição e método para o tratamento de seres humanos utilizando dietas com baixo teor de fodmap
EP3897207A1 (en) 2018-12-21 2021-10-27 Société des Produits Nestlé S.A. A nutritional composition comprising 2'-fucosyllactose (2' fl) to improve the gastrointestinal barrier
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
ES3036228T3 (en) 2019-02-25 2025-09-16 Nutribam Bv Composition comprising human milk oligosaccharide for use in supporting and/or improving intestinal health
BR112022010040A2 (pt) * 2019-11-27 2022-08-16 Glycom As Mistura de hmos
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
CN115772489B (zh) * 2022-12-23 2025-06-24 江南大学 一种能够缓解抗生素相关性腹泻的复合微生态制剂
CN117286078B (zh) * 2023-11-21 2024-02-02 四川厌氧生物科技有限责任公司 一种改善胃肠道健康的植物乳植杆菌及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
PT1991690E (pt) 2006-03-09 2014-04-22 Centre Nat Rech Scient Método para a produção de oligossacáridos sialilados
WO2010100979A1 (ja) 2009-03-05 2010-09-10 日産自動車株式会社 双極型二次電池及びその製造方法
EP2417143B1 (en) 2009-04-07 2016-12-21 Glycom A/S Synthesis of 2'-o-fucosyllactose
CN105330705A (zh) 2010-02-19 2016-02-17 格礼卡姆股份公司 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法
RU2013106897A (ru) 2010-07-16 2014-08-27 Глюком А/С Получение производных олигосахаридов
SG191798A1 (en) * 2010-12-31 2013-08-30 Abbott Lab Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
CN108741083A (zh) * 2010-12-31 2018-11-06 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
CN103429604A (zh) 2011-02-21 2013-12-04 格礼卡姆股份公司 寡糖前体的混合物的组合物的催化氢解及其用途
AU2012232727A1 (en) 2011-03-18 2013-09-26 Glycom A/S Synthesis of new fucose-containing carbohydrate derivatives
WO2012156898A1 (en) 2011-05-13 2012-11-22 Glycom A/S DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF
WO2012155916A1 (en) 2011-05-13 2012-11-22 Glycom A/S Manufacture of lacto-n-tetraose
EP2707493A4 (en) 2011-05-13 2014-10-08 Glycom As PROCESS FOR THE PREPARATION OF HUMAN MILK OLIGOSACCHARIDES (HMO) OR PRECURSORS THEREOF
CN104023560A (zh) * 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
EP2760875A4 (en) 2011-09-30 2015-08-26 Glycom As SYNTHESIS OF HMO NUCLEAR STRUCTURES
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2013139344A1 (en) 2012-03-20 2013-09-26 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
WO2013154725A1 (en) * 2012-04-13 2013-10-17 Trustees Of Boston College Prebiotic compositions and methods of use
WO2013161820A1 (ja) * 2012-04-23 2013-10-31 国立大学法人京都大学 ビフィズス菌の増殖促進用組成物
RU2016123464A (ru) 2013-11-15 2017-12-20 Нестек С.А. Композиции для применения в целях профилактики или лечения некротизирующего энтероколита у детей грудного или младшего возраста, рожденных с помощью кесарева сечения
WO2015095747A1 (en) 2013-12-20 2015-06-25 Abbott Laboratories Oral rehydration composition with oligosaccharides
WO2015153841A1 (en) 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
CN106132420A (zh) * 2014-04-08 2016-11-16 雅培公司 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
US20160346303A1 (en) * 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2017084673A1 (en) 2015-11-17 2017-05-26 Glycom A/S Synthetic Composition for Treating Antibiotic Associated Complications
ES2938355T3 (es) 2016-05-05 2023-04-10 Glycom As Composición que comprende HMOS para el tratamiento de la diarrea no infecciosa

Also Published As

Publication number Publication date
EP3452050A1 (en) 2019-03-13
EP3452050B1 (en) 2022-11-23
EP3452050A4 (en) 2020-01-08
ES2938355T3 (es) 2023-04-10
WO2017190754A1 (en) 2017-11-09
PL3452050T3 (pl) 2023-06-12

Similar Documents

Publication Publication Date Title
DK3452050T3 (da) Composition comprising hmos for the treatment of noninfectious diarrhoea
IL258402B1 (en) Electroporation for obesity or diabetes treatment
IL256209A (en) Novel cannabinoid combination therapies for multiple myeloma (mm)
HUE058737T2 (hu) Eljárások arenaviridae vírusok okozta fertõzések kezelésére
IL247452A0 (en) Compounds for treatment of complement mediated disorders
LT3594238T (lt) Antikūno kompozicijos, skirtos navikų gydymui
PL3265053T3 (pl) Sposoby leczenia skóry
PT3377516T (pt) Composição para o tratamento do cancro
FI20165606A7 (fi) Lämpökäsittely
HUE059158T2 (hu) Eljárás pridopidin elõállítására
EP3298448A4 (en) OPTOGENETIC MICROSCOPE
HUE055263T2 (hu) 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére
HUE066912T2 (hu) Lennox-Gastaut szindróma kezelési eljárása fenfluramin alkalmazásával
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3524255T3 (da) Sammensætning til behandling af acne
HUE050944T2 (hu) Kezelési eljárás tradipitant alkalmazásával
PL3303567T3 (pl) Sposób sterylizacji lizatu płytkowego
BR112016022976A2 (pt) Métodos para o tratamento de hcv
IL282311A (en) Use of reboxetine to treat narcolepsy
DK3324824T3 (da) Fremgangsmåde til behandling af binokulare dysfunktioner
PL3978074T3 (pl) Terlipresyna do leczenia zespołu wątrobowo-nerkowego typu 1
HUE059496T2 (hu) Hõkezelési eljárás
DK3294769T3 (da) Behandling for multipelt myelom (mm)
HUE064604T2 (hu) Menotropin meddõség kezelésére
LT3377094T (lt) Susilpninto virulentiškumo bakterijos, skirtos piktybinių solidinių navikų gydymui